Premium
Factors associated with anastomotic recurrence after total mesorectal excision in rectal cancer patients
Author(s) -
Kim YoungWan,
Kim NamKyu,
Min ByungSoh,
Huh Hyuk,
Kim JinSoo,
Kim JeongYeon,
Sohn SeungKook,
Cho ChangHwan
Publication year - 2008
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21166
Subject(s) - medicine , anastomosis , colorectal cancer , total mesorectal excision , resection margin , surgery , stage (stratigraphy) , surgical margin , cancer recurrence , cancer , resection , paleontology , biology
Background In patients undergoing total mesorectal excision (TME), the clinical variables most relevant to anastomotic recurrence have not been identified. We evaluated factors associated with anastomotic recurrence in patients undergoing TME and the impact of a reduced distal margin on anastomotic recurrence. Methods Thirty‐eight patients with anastomotic recurrence were compared with 876 patients who received curative rectal cancer surgery. Patients were compared according to: (1) the presence of anastomotic recurrence (recurrence vs. recurrence‐free), (2) distal margin length (≤10 mm vs. >10 mm) and (3) additional treatment (none, adjuvant, or neoadjuvant). The risk factors for anastomotic recurrence were analyzed. Results In the recurrence group, an advanced T stage (T3 and T4) ( P = 0.01) microscopic distal margin involvement ( P = 0.002) and an elevated CEA level (>5 ng/ml) ( P = 0.04) were more commonly found. The incidence of anastomotic recurrence was not higher in the distal margin ≤10 mm group and did not differ according to additional treatment. The multivariate analysis showed that an advanced T stage (T3 and T4) and microscopic distal margin involvement were risk factors for anastomotic recurrence. Conclusion A distal margin ≤10 mm appears to be acceptable in terms of anastomotic recurrence. Patients with a positive distal margin, on the postoperative pathology, should be considered at high risk for anastomotic recurrence. J. Surg. Oncol. 2009;99:58–64. © 2008 Wiley‐Liss, Inc.